Robert W. Duggan - 28 Nov 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Ken Stratton
Issuer symbol
PLSE
Transactions as of
28 Nov 2023
Net transactions value
+$1,117,085
Form type
4
Filing time
30 Nov 2023, 19:25:50 UTC
Previous filing
20 Nov 2023
Next filing
01 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $1,117,085 +124,397 +0.34% $8.98 36,391,194 28 Nov 2023 Direct F1
holding PLSE Common Stock 492,069 28 Nov 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Volume-weighted average price.
F2 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.